A comprehensive view of Hospital/Clinical Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Logistic & Supply Chain Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Canada to buy 15,000 treatment courses of Roche’s Actemra IV tocilizumab injectable to treat adult patients hospitalized with COVID-19; an estimated 429 out of 1,000 patients hospitalized with COVID-19 are eligible for tocilizumab
Published: December 02, 2022 by Canada Newswire
European Medicines Agency accepts GSK's marketing authorization application for momelotinib for the treatment of myelofibrosis, a type of bone marrow cancer; myelofibrosis affects approximately 20,000 patients in the US
Published: December 02, 2022 by U.S. Regulated Equity Markets (Alternative Disclosure) via PUBT
FDA withdraws emergency use authorization of Eli Lilly’s bebtelovimab injectable COVID-19 antibody therapy, citing the therapy is most likely ineffective against Omicron BQ.1 and BQ.1.1; Lilly had supplied 60,000 doses of the drug to US government in Q3
Published: December 01, 2022 by SeeNews Pharmaceuticals
Lilly completes acquisition of Akouos, expanding its efforts to help people with genetic diseases; acquisition includes Akouos's portfolio of adeno-associated viral gene therapies to treat inner ear conditions, including sensorineural hearing loss
Published: December 01, 2022 by Eli Lilly & Co.
AstraZeneca showcases strength of hematology portfolio and pipeline across multiple hard-to-treat conditions at ASH 2022 December 10-13; eight approved and potential new medicines to be featured across more than 10 types of blood cancers and rare diseases
Published: November 30, 2022 by Business Wire

Ask us about our Logistic & Supply Chain market view

Trending Chart

Interactive chart with headline count